In the ongoing battle to prevent mother-to-child transmission of human immunodeficiency virus (HIV), not all weapons are being used: Only about half of HIV-exposed infants in some African countries received a minimal dose of the prevention drug nevirapine, say researchers at the University of Alabama at Birmingham. In a July 21, 2010 issue of the Journal of the American Medical Association, the researchers report that only 51...
Full Story: PhysOrg
